navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
Published 3 years ago • 1.5K plays • Length 54:02Download video MP4
Download video MP3
Similar videos
-
57:18
navigating the expanding treatment arsenal for er /her2- breast cancer
-
0:58
treatment approach for metastatic her2 positive breast cancer
-
44:23
metastatic breast cancer: leveraging clinical pathways to navigate a complex treatment landscape:
-
1:31:37
personalizing treatment decisions in her2-altered breast cancer
-
1:19
dr. lin on the treatment landscape in her2 metastatic breast cancer
-
32:54
raising the bar in her2-positive breast cancer
-
16:00
foundation frontiers: advanced breast cancer - updates to hr /her2- treatment landscape
-
1:35:31
leveraging targeted therapies to improve outcomes across the continuum of her2 breast cancer
-
1:53:03
changing landscape in the management of her2 positive locally advanced and metastatic breast cancer
-
1:16:56
navigating the integration of trop2-targeted therapy in tnbc and hr , her2- breast cancer
-
1:03:59
selecting and sequencing of her2-targeting therapies in her2-positive metastatic breast cancer
-
0:55
neoadjuvant treatment approach for her2 positive breast cancer
-
1:50
overview of recent changes to the treatment landscape for her2-positive crc
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
59:12
making precision decisions in high-risk hr , her2- metastatic breast cancer
-
51:24
her2 and her3 alterations as therapeutic targets of increasing significance in solid tumors
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
2:39
adam brufsky, md, phd, describes the treatment landscape of her2 metastatic breast cancer